Who founded ACatechol?

ACatechol was founded by Kollbe Ando Ahn in 2016.

How much funding has ACatechol raised?

ACatechol has disclosed $400K raised across 1 round.

Where is ACatechol headquartered?

ACatechol is headquartered in Santa Barbara, US.

ACatechol

Santa Barbara, US · Founded 2016 · Delaware corporation

ACatechol develops bioinspired surface treatment technologies to prevent infections in medical devices, particularly catheters, by inhibiting biofilm formation. The company serves hospitals and medical device manufacturers seeking to reduce catheter-related bloodstream infections and sepsis.

Biotech Healthtech Medical Devices New Materials

Founders & leadership

ACatechol was founded in 2016 by Kollbe Ando Ahn.

Kollbe Ando AhnChief Executive Officer

Phillip HoEVP of Product Development

Eric RyanChief Financial Officer

Jin-Soo AhnNamed on SEC filing

Byung-Jun AhnNamed on SEC filing

Board

Jinsoo AhnClinical Advisor

Reported raises · per SEC filings

Form D private placements

$400K disclosed across 1 round · 2016

▶$400KraisedFeb 2016 · 2 investors · Other Technology

Rule 506(b)

Officers, directors & promoters on the filing

Jin-Soo AhnExecutive Officer, Director
Eric Cook RyanDirector
Byung-Jun AhnExecutive Officer, Director

Offering amount: $400K
Amount sold: $400K
First sale: Feb 2016
Incorporated: Corporation, Delaware, 2016
Federal exemptions: 06b

Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Non-dilutive funding · 2 SBIR/STTR awards

Federal grants — no equity taken

Agency	Phase	Year	Amount
National Institutes of Health (NIH)National Institutes of Health	Phase I	2023	$273.5K
National Science Foundation	Phase I	2020	$255.9K

Source: SBIR.gov award data (U.S. Small Business Administration). SBIR/STTR awards are competitive federal R&D grants and contracts — non-dilutive capital alongside any venture rounds above.

Frequently asked questions

What does ACatechol do?: ACatechol develops bioinspired surface treatment technologies to prevent infections in medical devices, particularly catheters, by inhibiting biofilm formation. The company serves hospitals and medical device manufacturers seeking to reduce catheter-related bloodstream infections and sepsis.
Who founded ACatechol?: ACatechol was founded by Kollbe Ando Ahn in 2016.
How much funding has ACatechol raised?: ACatechol has disclosed $400K raised across 1 round.
Where is ACatechol headquartered?: ACatechol is headquartered in Santa Barbara, US.